EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Distinguishing tubal rupture from tubal abortion in ectopic pregnancies after methotrexate treatment: a retrospective cohort study

Asal Darwish, Sharon Avishalom, Inshirah Sgayer, Susana Mustafa Mikhail, Lior Lowenstein, Ala Aiob

Archives of Gynecology and Obstetrics · 2025

DOI: 10.1007/s00404-025-08069-5 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Archives of Gynecology and Obstetrics, 2025. Verfasst von Asal Darwish und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Galilee Medical Center, POB 21, 22100, Nahariya, Israel. Hauptthemen laut MEDLINE: Methotrexate, Abortifacient Agents, Nonsteroidal, Pregnancy, Ectopic, Fallopian Tube Diseases. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bar-Ilan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To identify clinical, sonographic, and laboratory characteristics that distinguish between tubal rupture and tubal abortion following methotrexate (MTX) treatment for ectopic pregnancy (EP) and to compare the morbidity associated with these 2 outcomes.

Methods

This retrospective cohort study included women treated with MTX for EP at Galilee Medical Center between 2012 and 2024. Data on clinical presentation, ultrasound findings, and laboratory values were analyzed. Uregint surgical interventions were classified as tubal rupture or tubal abortion based on intraoperative findings. A comparative analysis between these groups was performed, and multivariable modeling was used to identify predictors of tubal rupture.

Results

Among 280 women treated with MTX, 47 (16.7%) required urgent surgical intervention. Of these, 15 (34.9%) were confirmed as tubal rupture, while 28 (65.1%) were tubal abortion. Women with tubal rupture more frequently presented with free pelvic fluid on transvaginal ultrasound (64.3 vs. 28.6%, P = 0.045) and had significantly higher intraoperative blood loss (433 ± 143 mL vs. 250 ± 201 mL, P = 0.001). A multivariable logistic regression model identified free pelvic fluid as an independent predictor of tubal rupture (odds ratio: 6.09, 95% CI 1.23–30.09, P = 0.027). No significant differences in preoperative beta-hCG levels or other clinical symptoms were observed between the groups.

Conclusion

Tubal rupture and tubal abortion share overlapping clinical features, making differentiation with current diagnostic tools challenging. Free pelvic fluid on ultrasound is a significant indicator of tubal rupture, underscoring the importance of timely surgical intervention. Recognizing that tubal abortion may be a self-limiting condition in some cases offers opportunities to preserve fallopian tube integrity and reduce unnecessary surgeries. Further research is needed to improve diagnostic accuracy and explore conservative management strategies for tubal abortion. Date and number of trial registration: December 2024, 0138–24-NHR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethotrexateAbortifacient Agents, NonsteroidalPregnancy, EctopicFallopian Tube DiseasesAbortion, SpontaneousHumansFemalePregnancyRetrospective StudiesAdultRupture, SpontaneousUltrasonographyPregnancy, TubalDiagnosis, DifferentialAbortion, InducedFallopian Tubes

Stichwörter der Autor:innen

Beta-hCGFallopian tube preservationFree pelvic fluidPredictive factorsSurgical interventionTransvaginal ultrasoundTubal abortionTubal rupture

Substanzen

MethotrexateAbortifacient Agents, Nonsteroidal

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Galilee Medical Center, POB 21, 22100, Nahariya, Israel.
  • Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel.
  • Department of Obstetrics and Gynecology, Galilee Medical Center, POB 21, 22100, Nahariya, Israel. Ala.aiob@gmail.com.
  • Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel. Ala.aiob@gmail.com.

Förderung

  • Bar-Ilan University

Zitieren

APA

Darwish, A., Avishalom, S., Sgayer, I., Mikhail, S. M., Lowenstein, L., & Aiob, A. (2025). Distinguishing tubal rupture from tubal abortion in ectopic pregnancies after methotrexate treatment: a retrospective cohort study. Archives of Gynecology and Obstetrics. https://doi.org/10.1007/s00404-025-08069-5

Vancouver

Darwish A, Avishalom S, Sgayer I, Mikhail SM, Lowenstein L, Aiob A. Distinguishing tubal rupture from tubal abortion in ectopic pregnancies after methotrexate treatment: a retrospective cohort study. Archives of Gynecology and Obstetrics. 2025. doi:10.1007/s00404-025-08069-5

BibTeX
@article{Darwish2025,
  author = {Darwish, Asal and Avishalom, Sharon and Sgayer, Inshirah and Mikhail, Susana Mustafa and Lowenstein, Lior and Aiob, Ala},
  title = {Distinguishing tubal rupture from tubal abortion in ectopic pregnancies after methotrexate treatment: a retrospective cohort study},
  journal = {Archives of Gynecology and Obstetrics},
  year = {2025},
  doi = {10.1007/s00404-025-08069-5}
}
Kostenlos starten →